Today: 19 April 2026
Vodafone share price today hovers near 52-week high after buyback update, Q3 trading statement ahead
3 February 2026
1 min read

Vodafone share price today hovers near 52-week high after buyback update, Q3 trading statement ahead

London, Feb 3, 2026, 09:22 GMT — Regular session

Vodafone Group Public Limited Company (VOD.L) shares climbed 1.1% to 110.4 pence by 09:22 GMT, trading close to their highest level in the past 52 weeks.

At this stage, the stock is being evaluated more by its cash flow — the buybacks, dividends, and management’s next moves — than by big-picture strategies. That shifts focus sharply to near-term indicators, especially since Vodafone has already pushed up against the top of its one-year trading range.

Vodafone disclosed it purchased 146,082 ordinary shares on Feb. 2 via Merrill Lynch International at a volume-weighted average price of 108.66 pence, according to a company filing. The VWAP reflects the average price weighted by trade size across the day. These shares will be kept in treasury, the statement added.

A filing with the U.S. Securities and Exchange Commission revealed Vodafone’s issued share capital stands at 24,877,960,757 shares, with 1,464,046,841 held in treasury as of Jan. 30. The total voting rights registered at 23,413,913,916, the document noted—a crucial figure for shareholder disclosure requirements.

Hargreaves Lansdown data revealed the stock kicked off at 109.45p, fluctuating between that and 110.65p since. The screen indicated a year peak at 110.60p. Vodafone’s market cap stood near £25.9 billion.

The stock built on Monday’s 1.72% gain, closing at 1.09 pounds and just 0.22% shy of its 52-week peak. The FTSE 100 index also moved higher, according to MarketWatch data.

European shares hit a record high on Monday, driven by gains in banks and healthcare. Early losses from a drop in precious metals faded, helping lift the broader market.

Vodafone plans to pay an interim dividend of 2.25 euro cents per ordinary share on Feb. 5. The company said this amounts to roughly 1.951 pence per share, based on the FX rate fixed on Jan. 29. Its shares have been trading ex-dividend since Nov. 20, so new buyers won’t qualify for this payment.

Yet the situation works both ways. Sitting near its 12-month high, any hint of tightening cash flow or a cautious note could spark swift profit-taking.

Vodafone will release its Q3 FY26 trading update on Feb. 5, followed by the full FY26 results on May 12, as per its financial calendar.

Stock Market Today

  • 2 TSX Stocks Under $100 with Strong Upside Potential
    April 18, 2026, 9:56 PM EDT. CES Energy (TSX:CEU) and Bird Construction are two TSX-listed stocks priced below $100 that offer significant growth potential. CES Energy provides consumable chemical solutions to oil and gas producers, benefiting from rising service intensity and demand for advanced chemical treatments. Despite softer drilling activity, CES's revenue growth remains robust, supported by its asset-light model and strategic acquisitions. Macro trends like growing global energy demand and LNG infrastructure expansion further boost its outlook. Bird Construction, also trading under $100, stands out for its presence in the construction sector, which benefits from infrastructure spending and urban development. Both companies show disciplined capital allocation and resilient revenue drivers, making them attractive for investors seeking accessible entry points and potential capital appreciation on the TSX.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Tesco share price slips as grocery inflation cools — 3 dates investors are watching
Previous Story

Tesco share price slips as grocery inflation cools — 3 dates investors are watching

Hang Seng ends higher but tech slips: HSBC hits a new high as Tencent drags Hong Kong stocks
Next Story

Hang Seng ends higher but tech slips: HSBC hits a new high as Tencent drags Hong Kong stocks

Go toTop